Inside the Lab

Do you cut corners when it comes to laboratory safety? 

Little things like carrying your cell phone, rolling up the sleeves of your lab coat, or skipping the hurricane drill don’t seem like a big deal in the moment. But when you consider the potential risks to you, your colleagues, your family, and anyone else you might encounter, even small safety violations can have a big impact. 

On this episode of Inside the Lab, your hosts, Ms. Kelly Swails, MT(ASCP), and Dr. Ali Brown, MD, FASCP, are joined by Mr. Sean Kaufman, MPH, CPH, IFBA-CP, CEO and Founding Partner of Safer Behaviors, Dr. Jason Nagy, PhD, MLS(ASCP), QLS, Laboratory Safety Support Coordinator for Sentara Healthcare, and Mr. Dan Scungio, MT(ASCP), SLS, CQA(ASQ), Laboratory Safety Consultant and Laboratory Safety Officer at Sentara Healthcare, to discuss the most common safety issues facing today’s medical labs. 

Our panelists explore the risks involved in having our cell phones in the medical laboratory and explain why so many leaders fail to hold their teams accountable for laboratory safety. 

Mr. Kaufman, Dr. Nagy, and Mr. Scungio describe why effective education is key in establishing a safety culture in the lab and how some of the things we do for the sake of safety increase our risk. 

Listen in for insight on effective emergency management planning and learn how to protect yourself and others from the greatest safety risks we face in the medical lab. 

Topics Covered 
· The top 10 safety issues facing today’s medical laboratories
· The surprising personal items that have been found in drawers during lab safety audits
· Examples of specimen transport safety issues 
· The 3 Cs of transferring specimens—coordination, communication, and common courtesy
· The risks involved in having cell phones in the medical laboratory
· Why effective education is key in establishing a safety culture in the lab (and what that looks like)
· Advice on preparing for emergencies that don’t occur often
· How laboratory leaders fail to hold their teams accountable for lab safety
· How we cut corners around PPE compliance (lab coats, goggles and face shields)
· The challenges around defining clean vs. dirty areas of the laboratory
· Why most laboratories are lacking when it comes to chemical and waste management
· How some of the things we do for the sake of safety increase our risk
· How human risk factors (i.e.: interpersonal conflict, mental and emotional fitness, etc.) are the greatest safety risks we face in the medical laboratory 

Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter

Connect with Mr. Kaufman
Safer Behaviors
Mr. Kaufman on LinkedIn

Connect with Dr. Nagy
Sentara Healthcare
Dr. Nagy on LinkedIn

Connect with Mr. Scungio
Dan the Lab Safety Man
Mr. Scungio on LinkedIn

Connect with Ms. Swails & Dr. Brown
Ms. Swails on Twitter
Dr. Brown on Twitter

Resources
Lablogatory
OSHA
Inside the Lab in the ASCP Store 

Are you ready for Medical Laboratory Professionals Week?  

Our annual celebration of pathologists and medical laboratory professionals begins April 23, 2023, and this year’s theme is Saved by the Lab, a play on the popular sitcom from the 1990s, Saved by the Bell. In honor of Zack Morris and friends from Bayside High, we’re revisiting the ‘90s to explore what was going on in the world—and the world of laboratory medicine. 

On this LIVE episode of Inside the Lab, your host, Ms. Kelly Swails, MLS(ASCP), is joined by Dr. Robert A. Goulart, MD, MASCP, FCAP, Associate Chief of Anatomic Pathology and Director of Quality and Patient Safety at the University of Massachusetts Memorial Health System and President-Elect of ASCP, Mr. Sean McNair, MPH, Cytology Education Coordinator at the Memorial Sloan Kettering Cancer Center and Program Director for the Cytology Training Program at Hunter College, Ms. Stephanie Y. Whitehead, MPH, MBA, MLS(ASCP), Executive Director of Pathology and Laboratory Services at University Health System in San Antonio, Texas, and Chair Elect for the Council of Laboratory Professionals, and Dr. Constantine Kanakis, MD, MSc, MLS(ASCP), Resident Physician at Loyola Medicine in Chicago and Member of the ASCP Patient Champions Advisory Board, for a ‘90s trivia showdown. 

Our panelists answer questions about ‘90s pop culture, including the highest grossing movies, chart-topping music and hottest toys of the decade.Dr. Goulart, Mr. McNair, Ms. Whitehead and Dr. Kanakis also test their knowledge of noteworthy lab news from the ‘90s. Listen in to find out which of our panelists took home the coveted prize, a tote bag filled with Saved by the Lab gear! 

Topics Covered
· Popular ‘90s trends such as the Tamagotchi, Tickle Me Elmo, Harry Potter and reality television
· ‘90s pop culture trivia, e.g.: the most-watched episode of TV, highest grossing movie and chart-topping music of the decade
· Lab-specific ‘90s trivia like when ASCP elected a laboratory professional to the Board of Directors for the first time or how many lab professionals were working in the US at that time
· Noteworthy laboratory news from the ‘90s, including Marie Gatscha’s testimony to Congress on behalf of ASCP, the revision of the WHO Blue Book on bone tumors, and trastuzumab’s impact on breast cancer treatment 

Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter 

Connect with Dr. Goulart
Dr. Goulart on LinkedIn 

Connect with Mr. McNair
Mr. McNair on LinkedIn 

Connect with Ms. Whitehead
Ms. Whitehead on LinkedIn
Ms. Whitehead on Twitter
Ms. Whitehead on Instagram 

Connect with Dr. Kanakis
Dr. Kanakis on LinkedIn
Dr. Kanakis on Twitter
Dr. Kanakis at Loyola Pathology 

Connect with Ms. Swails
Ms. Swails on Twitter 

Resources
ASCP Lab Week Resources
Inside the Lab in the ASCP Store 

The medical laboratory is often seen as a black box that generates definitive results with little effort. But it’s not always that simple.

What if you work up a culture and find an unusual bacteria or fungus? What do the technologists in the microbiology laboratory do to investigate these uncommon cases and provide their patients with a proper diagnosis? 

On this episode of Inside the Lab, our hosts, Ms. Kelly Swails, MLS(ASCP), and Dr. Ali Brown, MD, FASCP, are joined by Dr. Clare McCormick-Baw, MD, FASCP, Medical Director of Infectious Diseases Serology and Molecular Microbiology at Parkland Health in Dallas, Texas, and Assistant Professor in the Department of Pathology at the University of Texas Southwestern Medical Center, Dr. Andrew Clark, PhD, D(ABMM), Medical Directory of the Microbiology Laboratory at Clements University Hospital and Assistant Professor at the University of Texas Southwestern Medical Center, and Dr. Laura Filkins, PhD, D(ABMM), Clinical Microbiology Laboratory Director at Children’s Health System of Texas in Dallas, Texas, and Assistant Professor of Pathology at the University of Texas Southwestern Medical Center, to share their most interesting microbiology cases. 

Dr. Clark discusses an immunosuppressed 73-year-old man with persistent diarrhea who was diagnosed with invasive GI mucormycosis, and Dr. McCormick-Baw describes the case of the healthy 51-year-old woman whose abdominal fullness was caused by coccidioidomycosis, not cancer.  Listen in for Dr. Filkins’ insight on getting the CDC involved when a four-year-old patient contracted Burkholderia pseudomallei and learn how committed clinical laboratory scientists kept digging until they found answers for these three unique patients!

Topics Covered
· Dr. Clark’s case of an immunosuppressed 73-year-old man with persistent diarrhea
· How Dr. Clark’s team found Mucor mold in their patient’s stool culture and diagnosed him with invasive GI mucormycosis
· How rare GI mucormycosis is and why it’s nearly always terminal
· Dr. McCormick-Baw’s case of a healthy 51-year-old woman who presented with abdominal fullness
· How Dr. McCormick-Baw’s team determined that their patient did not have cancer but did have coccidioidomycosis
· Why it took two years after Dr. McCormick-Baw’s patient contracted Coccidioides on a hike for symptoms to present
· Dr. Filkins’ case of a previously healthy four-year-old female (with a colorful animal history) who presented with nausea, vomiting, lethargy and decreased appetite
· How Dr. Filkins’ team cultured their young patient’s tracheal aspirate specimen and found the high-risk pathogen Burkholderia pseudomallei
· How the local health lab, local epidemiologist and CDC’s joint investigation uncovered four cases of Burkholderia pseudomallei in the U.S. and traced them to aromatherapy bottles manufactured in India
· How the CDC, EPA and Texas public health agencies discovered that Dr. Filkins’ patient’s pet raccoon died of Burkholderia pseudomallei and decontaminated its burial site

Connect with ASCP
ASCP on Twitter
Connect with Dr. McCormick-Baw
Dr. McCormick-Baw at UT Southwestern
Connect with Dr. Clark
Dr. Clark at UT Southwestern
Connect with Dr. Filkins
Dr. Filkins at UT Southwestern
Resources
‘Burkholderia Pseudomalliei Detected in a Raccoon Carcass Linked to a Multistate Aromatherapy-Associated Melioidosis Outbreak’ in Morbidity and Mortality 

ASCP is committed to developing policies that improve public health through the practice of laboratory medicine. One of the ways that the Society participates in public policy is through our delegation to the American Medical Association (AMA).  

So, what does it mean to be an ASCP delegate to the AMA? How well is pathology represented within the AMA House of Delegates? And why does that representation matter? 

On this episode of Inside the Lab, your hosts Dr. Ali Brown, MD, FASCP, and Dr. Lotte Mulder, PhD, are joined by ASCP delegates to the AMA Dr. William Finn, MD, MASCP, Medical Director of the Joint Venture Hospital Laboratories and Past President of ASCP, Dr. Jennifer Stall, MD, Anatomic and Clinical Pathologist at Hospital Pathology Associates in Minneapolis-Saint Paul, Minnesota, and Dr. H. Cliff Sullivan, MD, Assistant Professor in the Department of Pathology and Laboratory Medicine and Director of the Cellular Therapy Laboratory at Emory University, to discuss laboratory medicine’s representation within the American Medical Association. 

Our panelists discuss the AMA’s function as a professional association and lobbying group for physicians and medical students and share their experiences as delegates to the AMA from ASCP.  Dr. Finn, Dr. Stall, and Dr. Sullivan explain the responsibilities as delegates to the AMA and offer examples of how ASCP’s involvement in the AMA serves the interests of ASCP members and our patients.  Listen in for insight around the AMA initiatives and programs pathologists should be aware of and learn how you can get involved in amplifying the voice of pathologists in the AMA. 

Topics Covered 
· How the AMA functions as a professional association and lobbying group for physicians and medical students
· How the AMA fulfills its mission to promote the art and science of medicine and the betterment of public health
· Who serves as ASCP’s full delegates to the AMA and who serves as alternate delegates
· How well pathology is represented within the AMA and why that representation matters
· How the pathology voice is received in the egalitarian system of the AMA
· How ASCP’s involvement in the AMA serves the interests of ASCP members and our patients
· How to get involved with the AMA 

Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter
Connect with Dr. Finn
Dr. Finn on LinkedIn
Connect with Dr.Stall
Dr. Stall on Twitter
Connect with Dr. Sullivan
Dr. Sullivan at Emory University
Connect with Dr. Mulder & Dr. Brown
Dr. Mulder on Twitter
Dr. Brown on Twitter
Resources
American Medical Association
ASCP Resident Council
VALID Act of 2021
CLIA Law & Regulations
ASCP Institute for Science, Technology and Public Policy
Inside the Lab in the ASCP Store 

ASCP’s Resident In-Service Exam, better known as RISE, began in 1983, and it was designed as a study tool for board exams.  

But RISE has evolved over time in response to feedback from program directors and residents alike, adapting to remain relevant to practice and help students identify their individual strengths and weaknesses.

 So, what do you need to know about the Resident In-Service Exam and how it can ensure your success as an emerging pathologist or laboratory professional?  

On this episode of Inside the Lab, your hosts Dr. Ali Brown, MD, FASCP, and Ms. Kelly Swails, MT(ASCP), are joined by Mr. Jay Wagner, MBA, MLS(ASCP), Director of Assessment, Measurement, Evaluation, Examinations and Outcomes at ASCP, and Dr. Jonathan Genzen, MD, PhD, Associate Professor at the University of Utah, CMO at ARUP Laboratories and Chair of the RISE Committee, to discuss the evolution of ASCP’s Resident In-Service Exam. 

Mr. Wagner and Dr. Genzen discuss who is responsible for writing questions for RISE, what that process looks like, and why the committee doesn’t repeat questions from year-to-year. The panelists explain how RISE supports you in learning from the questions you miss and why there’s such a significant correlation between RISE scores and ABPath pass rates. Listen in for insight on how to study for RISE and learn how the exam helps gauge residents’ progress in becoming the next generation of pathologists and laboratory professionals!

Topics Covered 
· How ASCP’s Resident In-Service Exam has evolved since its inception 
· Who is responsible for writing the questions for RISE and what the process looks like
· How the RISE Committee makes the exam relevant for international participants
· The correlation between Resident In-Service Exam scores and ABPath pass rates
· How RISE is scored and how it helps you learn from the questions you miss
· When RISE is given and how you can take it all four years of your residency
· How the online format gives program directors flexibility in the administration of RISE
· RISE’s purpose in gauging resident progress and identifying strengths and weaknesses
· Using the Resident Question Bank to study for RISE

Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter 

Connect with Mr. Wagner
Mr. Wagner on LinkedIn

Connect with Dr. Genzen
Dr. Genzen at the University of Utah
Dr. Genzen on LinkedIn 

Connect with Ms. Swails & Dr. Brown
Ms. Swails on Twitter
Dr. Brown on Twitter

Resources
ASCP Resident In-Service Exam
ASCP Resident Question Bank [Promo Code POD50]
Inside the Lab in the ASCP Store 

Castleman Disease: Case-based Microlearning  Activity Overview

This CME/CMLE-accredited, case-based microlearning activity is designed to help laboratory team members increase their knowledge, skills, and competence in diagnosing multicentric Castleman disease and to be informed of changes in clinical practice guidelines. Through a series of four 15-minute cases developed by a multidisciplinary team, you will gain a greater understanding of multicentric Castleman disease, how to differentiate it from potential mimics, and updated guidelines for diagnosis. The activity offers 1.0 CME/CMLE credit.

Target Audience The target audience for this activity consists of pathologists and laboratory professionals.   

Activity Agenda
 ·         Introduction to Castleman disease
 ·         Case-based approach to diagnosing Castleman disease, featuring multidisciplinary perspectives

Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 
Credit Designation Statement
The ASCP designates this online microlearning activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  ASCP designates this online microlearning activity for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel. For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

Method of Participation To complete the activity and receive credit, the participant must complete all four cases in the microlearning activity. CME certificates will be provided online. 
Commercial Support This activity is funded by an independent educational grant from Recordati Rare Diseases Inc.. 

Faculty
Anamarija Perry, MD
Associate Professor, Hematopathology, Department of Pathology, Michigan Medicine, University of Michigan
David Fajgenbaum, MD, MBA, MSc
Assistant Professor of Medicine, Translational Medicine & Human Genetics, University of Pennsylvania
Seth Kligerman, MD 
Professor, Division Chief of Cardiothoracic Radiology, Department of Radiology, University of California, San Diego 

Data is fundamental to the modern world. From education to healthcare to economic development and public policy, we rely on data to allocate resources and make decisions. 

In Caroline Criado Perez’s groundbreaking book, Invisible Women: Exposing Data Bias in a World Designed for Men, she contends that there’s a gender data gap. And because the bulk of the world’s data is based on male bodies and behaviors, we live in a world that caters to men and disadvantages women. How does this gender data gap impact women in pathology and laboratory medicine? And what can we do to make the profession more inclusive? 

On this episode of Inside the Lab, Host Kelly Swails, MT(ASCP), is joined by Dr. Alison Krywanczyk, MD, FASCP, Deputy Medical Examiner at the Cuyahoga County Medical Examiner's Office in Cleveland, Ohio, Dr. Letycia Catalina Nunez-Argote, PhD, MPH, MLS(ASCP)CM, Assistant Professor of Clinical Laboratory Sciences at the University of Kansas Medical Center in Kansas City, Kansas, and Dr. Catherine M. Stefaniuk, DO, MBA, FASCP, Assistant Medical Director of Clinical Pathology at the University of Cincinnati Medical Center, for an ASCP Leadership Institute Book Club discussion of Invisible Women.

Dr. Krywanczyk, Dr. Nunez-Argote, and Dr. Stefaniuk discuss the unpaid work many women do and share their experiences with the changing roles of breadwinner and homemaker between the genders. They explore the negative perceptions of women in positions of authority and explain how the myth of meritocracy has impacted their careers in pathology and laboratory medicine. Listen in for insight on designing laboratory spaces for women and learn to leverage your knowledge as a medical professional to advocate for women in the healthcare system.

Topics Covered
· How the gender data gap in healthcare caters to men and actively disadvantages women
· The unpaid work most women do and the changing roles of breadwinner and homemaker between the genders
· Why so many women trade flexibility for advancement and how working part-time disadvantages women in terms of healthcare and retirement benefits
·  How the gender data gap impacts pathology and laboratory medicine and what we can do to make the laboratory more amenable to women
· The negative perceptions of women in positions of authority and how that impacts the way we work
·  Situations where our knowledge as medical professionals can help us advocate for women whose symptoms are not understood or believed
· How insights gained from Invisible Women will influence decision-making moving forward 

Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter
Connect with Dr. Krywanczyk
Dr. Krywanczyk on Twitter
Connect with Dr.Nunez-Argote
Dr. Nunez-Argote on Twitter
Connect with Dr. Stefaniuk
Dr. Stefaniuk on LinkedIn

Resources
ASCP Leadership Institute
Invisible Women: Exposing Data Bias in a World Designed for Men by Caroline Criado Perez
Inside the Lab in the ASCP Store 

In medicine, we’re taught to recognize hoofbeats as horses rather than zebras. But what happens when a surgical pathology diagnosis really is a zebra? 

What is the best way to approach a challenging case? And how do you know when to ask for help? 

On this episode of Inside the Lab, our hosts, Ms. Kelly Swails, MT(ASCP), and Dr. Ali Brown, MD, FASCP, are joined by Dr. Cesar Moran, MD, Tenured Professor of Pathology at the University of Texas MD Anderson Cancer Center, to share some of the most challenging surgical pathology cases he’s faced. 

Dr. Moran describes three different types of difficult cases and discusses what to do when a tumor appears to be a new entity. Listen in for Dr. Moran’s insight on fighting against the bias of your default diagnosis and get his advice on how to know when you don’t know and ask your colleagues for help.  

Topics Covered 
· Dr. Moran’s take on the 3 different types of challenging surgical pathology cases
· How the expectations for surgical pathologists to provide a diagnosis have risen exponentially
· The volume of tissue issue in thoracic pathology
· Dr. Moran’s approach to a challenging surgical pathology case
· What to do when a tumor appears to be a new entity
· Why pathologists are unlikely to be replaced by technology
· How the diagnostic tools for surgical pathologists have evolved from electron microscopy to immunohistochemistry to molecular studies
· Examples of the most challenging cases Dr. Moran has faced in his career
· Why it’s challenging to consider unusual possibilities when you come in with a default diagnosis
· How to fight against the bias of default diagnosis
· Why Dr. Moran considers benign diagnoses to be the most difficult ones
· Dr. Moran’s advice for practicing pathologists on when to ask colleagues for help

 Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter 

Connect with Dr. Moran
Dr. Moran at MD Anderson
Dr. Moran on LinkedIn 

Connect with Ms. Swails & Dr. Brown
 Ms. Swails on Twitter
Dr. Brown on Twitter 

Resources
Become a Member of ASCP
‘Xanthomatous Thymoma: A Clinicopathologic and Immunohistochemical Study of 10 Cases’ in the American Journal of Clinical Pathology
Inside the Lab in the ASCP Store 

Medical laboratories, in general, struggle with visibility. And laboratory professionals rarely get the recognition they deserve for the important work that they do. The Leading Laboratories program is on a mission to change that. This partnership between ASCP and The Joint Commission seeks to recognize excellence in laboratory practice, awarding the Leading Laboratories designation to labs with an exemplary focus on impacting quality patient outcomes. 

On this episode of Inside the Lab, our hosts, Ms. Kelly Swails and Dr. Ali Brown, are joined by Ms. Barbara Caldwell, MS, MASCP, MLS(ASCP)SHCM, Former Administrative Director of Clinical Laboratory Services at MedStar Montgomery Medical Center in Olney, Maryland; Ms. Lynnette Chakkaphak, MS, MLS(ASCP), Director of Clinical Operations at Ascension St. Vincent's Riverside Hospital in Jacksonville, Florida; and Ms. Diana Kremitske, MHA, MS, MLS(ASCP), Vice President of the Diagnostic Medicine Institute at Geisinger in Danville, Pennsylvania, to discuss the new Leading Laboratories program. 

Ms. Caldwell, Ms. Chakkaphak, and Ms. Kremitske describe their involvement in the development of Leading Laboratories and explain how a laboratory earns the prestigious designation. Listen in to learn how to follow the program’s roadmap for building strong, successful medical laboratories across the country. 

Topics Covered 
· The goal of the Leading Laboratories program and how a lab earns the prestigious designation
· What differentiates the Leading Laboratories designation from laboratory accreditation
· The four key components of the Leading Laboratories program
· How to compile and submit a portfolio of evidence to the Leading Laboratories program
· How the Leading Laboratories program addresses the workforce recruitment and retention crisis among pathologists and medical laboratory professionals
· How The Joint Commission’s involvement in Leading Laboratories impacts its visibility among executives in hospital C-suites
· How Leading Laboratories provides a roadmap to build stronger, more successful laboratories across the country 

Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter 

Connect with Ms. Caldwell
Ms. Caldwell on LinkedIn

Connect with Ms. Chakkaphak
Ms. Chakkaphak on Twitter
Ms. Chakkaphak on LinkedIn

Connect with Ms. Kremitske
Ms. Kremitske on Twitter
Ms. Kremitske on LinkedIn

Connect with Ms. Swails & Dr. Brown
Ms. Swails on Twitter
Dr. Brown on Twitter

Resources
Leading Laboratories Program
Inside the Lab in the ASCP Store 

During this recorded 2022 ASCP Annual Meeting session, multidisciplinary faculty will discuss the science and latest evidence on emerging biomarkers, resistance mutations, immuno-oncology (I-O) resistance mechanisms, and I-O treatment options (e.g., combination therapy involving CTLA-4 inhibitors) in metastatic NSCLC.  In addition, they will address how to integrate next generation sequencing (NGS) into your biomarker testing workflows and optimize its use for patients.  Finally, they will share best practices in biomarker testing, reporting, and communication to help pathologists and laboratory professionals guide medical oncologists and other team members in the appropriate diagnosis, testing, and treatment for patients.  

The activity offers 1.0 CME/CMLE credit.  

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  

 Learning Objectives

Upon completion of this activity, you should be able to:
·         Describe ongoing investigational efforts regarding emerging biomarkers in metastatic NSCLC 
·         Utilize NGS to identify current and emerging biomarkers to predict response to personalized therapies for patients with metastatic NSCLC 
·         Employ strategies for optimizing workflows and turnaround times for NGS 
·         Discuss the science behind resistance mechanisms in patients with metastatic NSCLC 
·         Recognize the use of emerging I-O combination therapies and potential biomarkers in patients with metastatic NSCLC 
·         Develop ways to improve communication among pathologists, oncologists, and other members of the multidisciplinary lung cancer care team 

Faculty

Diana N. Ionescu MD, FRCPC, FCAP
Consultant Pathologist and Medical Lead Anatomical Pathology 
Medical Director BC Cervical Cancer Screening Laboratory 
Medical Director Clinical Trials, BC Cancer Laboratories 
Clinical Professor of Pathology, University of British Columbia 

Doru Paul, MD, PhD
Attending Physician, Division of Hematology and Medical Oncology 
Weill Cornell and New York Presbyterian Hospital  

Faculty Disclosures

The following Panel/Faculty members have relevant financial relationships to disclose: 

 | Faculty Member | Ineligible Company | For what role?
| Diana Ionescu, MD | AstraZeneca, Bayer, BMS, Merck, Pfizer, Roche | Consultant, Consultant, Consultant, Consultant, Consultant, Consultant 

Dr. Paul has no relevant financial relationships to disclose 

All of the relevant financial relationships listed for these individuals have been mitigated  

Commercial Support
Funded by an independent educational grant from AstraZeneca Pharmaceuticals